Evidence map›Paper›PMID 40934106›Full record

ArticleMicrobial genomics2025

Dissemination of OXA-23 carbapenemase-producing

Roxana Zamudio, Karen Osman, Rachel Pike, Aiysha Chaudhry, Danièle Meunier, Nicole Stoesser, Rebecca Stretch, Jane F Turton, David Williams, Katie L Hopkins

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbial genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Detection of OXA-23 and OXA-58 inMicrobiology spectrum · 2026
    Article
  2. Extensively Drug-Resistant ST16Infection and drug resistance · 2026
    Article
  3. Description on the prevalence ofFrontiers in microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Roxana ZamudioAMR and HCAI Division, UK Health Security Agency (UKHSA), London, UK.
Karen OsmanAMR and HCAI Division, UK Health Security Agency (UKHSA), London, UK.
Rachel PikeAntimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, Public Health Microbiology - Reference Microbiology Division, UK Health Security Agency (UKHSA), London, UK.
Aiysha ChaudhryAntimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, Public Health Microbiology - Reference Microbiology Division, UK Health Security Agency (UKHSA), London, UK.
Danièle MeunierAMR and HCAI Division, UK Health Security Agency (UKHSA), London, UK.
Nicole StoesserNuffield Department of Medicine, University of Oxford, Oxford, UK.
Rebecca StretchAMR and HCAI Division, UK Health Security Agency (UKHSA), London, UK.
Jane F TurtonAMR and HCAI Division, UK Health Security Agency (UKHSA), London, UK.
David WilliamsAMR and HCAI Division, UK Health Security Agency (UKHSA), London, UK.
Katie L HopkinsAMR and HCAI Division, UK Health Security Agency (UKHSA), London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenem-resistant

Indexed as

Bacterial Proteinsbeta-LactamasesDNA Transposable ElementsEscherichia coliProteus mirabilisAnti-Bacterial AgentsEscherichia coli InfectionsGenome, BacterialHumansMicrobial Sensitivity TestsPhylogenyPolymorphism, Single NucleotideProteus InfectionsUnited KingdomWhole Genome SequencingAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseDNA Transposable ElementscarbapenemaseEscherichia coliOXA-23Proteus mirabilistransposon

Identifiers

PMID40934106
PMCPMC12426204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.